IDXX
HEALTHCAREIDEXX Laboratories Inc
IDEXX Laboratories Inc (IDXX) is currently trading at $545.73, down 2.91% today. The stock remains below key moving averages, with a 20-day simple moving average (SMA) at $560.85, a 50-day SMA at $561.07, and a 200-day SMA at $632.08. The relative strength index (RSI) stands at 44.6, indicating that the stock is approaching oversold territory. The MACD shows a negative trend with a value of -0.74, suggesting bearish momentum. The current market capitalization is $44.34 billion, reflecting a significant position in the diagnostics and research sector.
From a fundamental perspective, IDEXX exhibits robust growth metrics, including a quarterly revenue growth rate of 14.3% and an impressive year-over-year revenue growth of 1042.2%. The company maintains extraordinary margins, with a gross margin of 6179.7% and an operating margin of 3160.1%. The price-to-earnings (P/E) ratio stands at 41.3, with a forward P/E of 38.2, indicating that the stock is priced for growth given its historical EPS growth of 17.2%. Analysts are generally optimistic, with a consensus rating of "BUY" supported by 4 strong buy, 5 buy, and 5 hold recommendations, and a target price of $709.14, suggesting substantial upside potential.
Currently, IDEXX does not have an earnings report scheduled within the next 30 days, with the last quarter reported on March 31, 2026. One notable aspect to monitor is the company's exceptional gross and operating margins, which, while currently strong, could be subject to scrutiny if they begin to show signs of compression due to rising costs or competitive pressures. Investors should keep an eye on any updates regarding margin stability and the overall revenue growth trajectory, as these factors will be critical in assessing the sustainability of IDEXX's high valuation in the coming months.
What's Moving IDXX Today?
No stock-specific AI insight has been generated for IDXX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$545.60
Fundamentals
Trading
IDXX News
41 articles- Danaher plans July 21 earnings call, slide deck at 6 a.m. ETStock Titan·Jun 22, 2026
- A Small Upgrade Could Have a Big Impact for IDEXX CustomersYahoo Finance·Jun 22, 2026
- IDEXX Laboratories Stock - Saturday deep dive into the long-term business modelAD HOC NEWS·Jun 20, 2026
- IDEXX Laboratories Inc Stock (US45167R1041): valuation metrics in focus for S&P 500 diagnostics nameAD HOC NEWS·Jun 15, 2026
- IDEXX Laboratories Stock’s 63% Gross Margin Story: Here’s What the Numbers Say About a $909 TargetTIKR.com·Jun 10, 2026
- Is IDEXX Laboratories Stock Underperforming the Nasdaq?Barchart·Jun 9, 2026
- Idexx (IDXX) Down 3.2% Since Last Earnings Report: Can It Rebound?Yahoo Finance·Jun 4, 2026
- IDEXX Parasite Test Expansion Links Zoonotic Risk And Valuation DebateYahoo Finance·Jun 3, 2026
- IDEXX (IDXX) EVP Fennell reports RSU vesting and tax share withholdingStock Titan·Jun 2, 2026
- IDEXX Laboratories Inc stock (US45167R1041): shares steady as investors digest AI strategy and sectoAd Hoc News·Jun 1, 2026
- IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel ConferenceMarketbeat·May 30, 2026
- IDEXX Laboratories (IDXX) Embeds an Early Kidney Disease Detector Into Its Most Popular Test ProfileInsider Monkey·May 27, 2026
- IDEXX Laboratories stock (US45168D1046): solid Q1 update keeps animal health growth story in focusAd Hoc News·May 27, 2026
- Is Wall Street Bullish or Bearish on IDEXX Laboratories Stock?Barchart·May 26, 2026
- IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm DetectionBusiness Wire·May 26, 2026
- 11 Best Medical Technology Stocks to Buy Right NowInsider Monkey·May 25, 2026
- Insider sale notice: IDEXX Labs (NASDAQ: IDXX) files Form 144Stock Titan·May 20, 2026
- Should IDEXX’s (IDXX) SDMA-Enhanced Catalyst Panels Prompt Action From Long-Term Diagnostics Investors?Yahoo Finance·May 20, 2026
- IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry ProfilesYahoo Finance·May 19, 2026
- Elyxium Wealth LLC Invests $3.67 Billion in IDEXX Laboratories, Inc. $IDXXMarketBeat·May 18, 2026
- IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day01net·May 14, 2026
- IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor DayBusiness Wire·May 14, 2026
- Do You Believe in the Long-Term Growth Potential of IDEXX Laboratories (IDXX)?Yahoo Finance·May 14, 2026
- IDEXX Laboratories stock (US45167R1041): Q1 earnings beat with 14.3% revenue growthAD HOC NEWS·May 14, 2026
- IDEXX Laboratories, Inc. Stock 12‑Month Price Target Cut to $714.36, Implies 35% UpsideTradingView·May 14, 2026
- IDEXX Laboratories, Inc. Stock 12‑Month Price Target Cut to $721.5, Implies 35% UpsideTradingView·May 13, 2026
- IDEXX Laboratories Inc (IDXX) Stock Down 4.7% -- Now Undervalued? GF Score: 98/100GuruFocus·May 13, 2026
- IDEXX Laboratories stock (US45167R1041): Shares fall 5% despite beating earnings estimatesAD HOC NEWS·May 12, 2026
- IDEXX (IDXX) director’s RSUs vest into 257 shares, holdings updatedStock Titan·May 11, 2026
- BofA Sees Slower InVue Installations as Headwind for IDEXX Laboratories, Inc. (IDXX)Yahoo Finance·May 11, 2026
- Analyst Estimates: Here's What Brokers Think Of IDEXX Laboratories, Inc. (NASDAQ:IDXX) After Its First-Quarter ReportYahoo Finance·May 7, 2026
- How Fluffy's Testing Service Outplayed Slow Vet Visits — AgainYahoo Finance·May 5, 2026
- IDEXX Laboratories Q1 Earnings Call HighlightsMarketbeat·May 5, 2026
- IDEXX Laboratories, Inc. Q1 2026 Earnings Call SummaryMoby·May 5, 2026
- Idexx (IDXX) Q1 2026 Earnings Call TranscriptMotley Fool·May 5, 2026
- IDEXX Stock Up on Q1 Earnings & Revenue Beat, Margins Rise, '26 View UpYahoo Finance·May 5, 2026
- Idexx (IDXX) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesYahoo Finance·May 5, 2026
Price Data
52-Week Range
$545.60
Fundamentals
Trading
About IDEXX Laboratories Inc
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.